Director Gino Santini sold Collegium Pharmaceutical, Inc. ($COLL) shares once on the open market in the last year, for a total of $201 thousand. His most recent sale occurred on August 15, 2025. These sales rank 8,393rd among 11,678 insiders by volume, well below the average of $8.6 million across 6.4 transactions. Santini made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 15, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | SANTINI GINO | Director | S | Common Stock | 5405 | $37.19 | 95,042.0000 | 39,075,703 | 5.38% | 0.01% |
| Aug. 15, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | SANTINI GINO | Director | M | Stock Option (Right to Purchase) | 15000 | $0.00 | 0.0000 | 39,075,703 | 100.00% | 0.04% |
| Aug. 15, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | SANTINI GINO | Director | M | Common Stock | 15000 | $13.45 | 100,447.0000 | 39,075,703 | 17.55% | 0.04% |
| June 12, 2025 | COMPASS Pathways plc | $CMPS | SANTINI GINO | Director | A | Share Option (Right to Buy) | 39000 | $0.00 | 39,000.0000 | 92,673,132 | 9999.99% | 0.04% |
| May 15, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | SANTINI GINO | Director | A | Common Stock | 9791 | $0.00 | 85,447.0000 | 32,840,153 | 12.94% | 0.03% |
| Sept. 3, 2024 | COMPASS Pathways plc | $CMPS | SANTINI GINO | Director | A | Share Option (Right to Buy) | 52000 | $0.00 | 52,000.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | SANTINI GINO | Director | A | Common Stock | 7693 | $0.00 | 75,656.0000 | 41,438,466 | 11.32% | 0.02% |
| May 18, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | SANTINI GINO | Director | A | Common Stock | 9792 | $0.00 | 67,963.0000 | 34,319,291 | 16.83% | 0.03% |